Author

Thomas Thompson

Institutions: University of Liverpool, Royal Liverpool University Hospital

Observed institutions: Queen's University Belfast, University of Liverpool, Wellcome Sanger Institute, Royal Liverpool University Hospital, Manchester University NHS Foundation Trust

ORCID: 0000-0002-4032-8954

Observed ORCID: 0000-0002-4032-8954

OpenAlex ID: A5037507299

SARS-CoV-2 evolution during treatment of chronic infection

2021 · Steven A. Kemp, Dami A. Collier, et al. · Nature · 1,093

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

2020 · Erik Volz, Verity Hill, et al. · Cell · 1,005

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

2021 · Dami A. Collier, Anna De Marco, et al. · Nature · 729

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

2021 · Bo Meng, Steven A. Kemp, et al. · Cell Reports · 407

Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

2022 · Dinesh Aggarwal, Ben Warne, et al. · Nature Communications · 54

Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

2022 · Dinesh Aggarwal, Andrew J. Page, et al. · Nature Communications · 16

Update on testosterone deficiency and therapeutic options for testosterone replacement therapy

2026 · Thomas Thompson, Mohamed Mubarak, et al. · Nature Reviews Urology

Extra-Anatomical Stents in Benign Ureteric Obstruction: Experience and Outcomes

2021 · Tom Brophy, Thomas Thompson, et al. · Journal of Endourology

Immunoglobulin G4–related disease of the paratestis: Can we avoid radical treatment?

2020 · Thomas Thompson, Thomas Brophy, et al. · Journal of Clinical Urology

Works count: 9

Citation count: 3,304

H-index: 6

I10-index: 6